Community/Retail

Poisonous mushrooms may hold the key to more efficiently treating diseases, findings from a recent study report.

The FDA has approved Imbruvica (ibrutinib) for the treatment of marginal zone lymphoma.

10-1074 was well-tolerated, demonstrated favorable pharmacokinetic properties, and had high antiviral activity among patients with HIV, a recent study found.

Fear of adverse drug events often influences adherence decisions.

A new study, published in Psychiatric Services, reveals a missed opportunity for early HIV detection and treatment.

The prevalence of diabetes is 17% higher in rural areas than in urban areas.

A recent study indicates that continuous medication monitoring (CoMM) could serve as a valuable tool for community pharmacists, shifting the focus from dispensing to improving patient outcomes and medication use.

Three people have been arrested for attempting to fill fraudulent prescriptions, thanks to a local pharmacist’s tip to law enforcement.

Your customer wants simple. They want a one-tap app that connects them to your brand.

The American Pharmacists Association (APhA) today announced the selection of the 2017 Awards and Honors Program recipients.

The FDA has finalized guidance designed to help investigational drug sponsors determine whether a new product can be potentially abused.

A new trivalent vaccine that has proven effective in the prevention of HSV-2 in animal trials could be headed for human trials soon.

To continue its efforts to fight hunger in the communities where SpartanNash associates live and work, the SpartanNash Foundation has recently made a series of $5,000 donations to 14 food pantries in 13 states.

As the voice of independent pharmacists, the National Community Pharmacists Association (NCPA) works to align our advocacy efforts with the most pressing legislative priorities of our members.

The Kroger Co. has announced that its total active workforce grew by more than 12,000 associates in 2016.

Pronunciation errors threaten patient safety, but what can we do about them?

With snow falling across the United States, the only thing on my mind is a sunny escape.

Cancer cells are much less efficient in removing hydrogen peroxide than normal cells.

A New Hampshire-based physician assistant (PA) is at the center of an investigation for his role in a fentanyl spray scam, according to NH1.

Researchers in England set out to determine whether the risk of diabetes development was present at the onset of schizophrenia, as opposed to after a period of time with the illness.

The FDA has announced 2 new draft guidances for medical product communications, such as off-label information and communicating cost-effective data

Marketed under the brand names Carac, Effudex and Fluoroplex, people using this medication should use care when applying and storing the medication if they are also in a household with pets, as even very small amounts could be dangerous to these animals.

The FDA has accepted the new drug application (NDA) for EZR-201, an investigational product from Ezra Innovations for the treatment of hypertension and heart failure.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Torbjörn Tomson, MD, PhD - professor in neurology, Karolinska Institutet - discusses how health care providers can work with patients to prevent sudden unexpected death in epilepsy (SUDEP).

A new CDC report assesses factors that influence pregnant women’s adherence to vaccination coverage recommendations.

Epilepsy medications can cause folate deficiency-related birth defects but what about other birth defects?

The FDA announced the approval of Trulance (plecanatide), Synergy’s once-daily oral treatment for chronic idiopathic constipation (CIC) in adult patients.